AI Nexus

Silicon Valley AI Nexus

posted: 11-Jun-2026 & updated: 11-Jun-2026

⚠️ Confidential | BSR Korea and Sunghee Yun Only | Not Publicly Listed

Prepared by: Sunghee Yun, Ph.D.
Date: June 11, 2026

Executive Summary

This proposal outlines the formation of a joint venture between BSR Korea and Sunghee Yun to establish a Korea–US technology commercialization bridge — a systematic business that identifies high-value technologies developed within Korean research institutions, and brings them to the US market for commercial development and global scaling.

Korea possesses world-class research output accumulated over more than five decades since the 1970s, housed within hundreds of Technology Licensing Offices (TLOs) and government-backed research institutes. However, these institutions structurally lack the capability, experience, and ecosystem to transform their intellectual property into profitable, globally competitive businesses. The United States — and Silicon Valley in particular — possesses exactly that capability.

This venture leverages a uniquely complementary partnership: BSR Korea’s deep institutional relationships with Korean TLOs and government entities, and Sunghee Yun’s extensive US network, reputation, and community platform built through Silicon Valley AI Nexus.

Critically, what makes this venture studio model exceptionally rare — and therefore defensible — is the combination of its components: deep Korean institutional access on one side, a functioning Silicon Valley ecosystem bridge on the other, and at the center, human capital with native-level fluency in both Korean and American business cultures, technical domains, and relationship networks. Each of these components is difficult to assemble independently; finding them unified in a single partnership is nearly unprecedented. This is not a business model that can be easily replicated by competitors, because the assets are fundamentally relational, reputational, and cultural — not capital-based.

Problem Statement

Korean government-funded research centers, national laboratories, and university TLOs have generated an enormous portfolio of advanced technologies across AI, biotechnology, semiconductors, advanced materials, and other frontier domains. Despite the quality of this research output, a persistent commercialization gap exists:

  • TLOs are structurally oriented toward research output and IP filing, not business building
  • Domestic commercialization pathways are limited by market size and risk-averse investment culture
  • International go-to-market (GTM) capabilities — particularly into the US — are largely absent
  • Government programs fund technology development but rarely sustain commercial execution

Meanwhile, the US ecosystem — venture capital (VC), corporate partnerships, talent, and market access — remains the world’s most effective engine for turning technology into scalable, profitable business.

The opportunity is clear: bridge these two worlds systematically.

Proposed Solution

Core Business Model

Establish a joint venture entity that operates as a technology commercialization intermediary between Korean research institutions and US markets:

  1. Source — Identify commercially promising technologies from Korean TLOs, government research institutes (출연연, e.g., ETRI, KIST, KRIBB, KISTI, and KAERI), and related entities
  2. Evaluate — Assess market fit, IP strength, and commercialization potential for the US market
  3. Package — Structure technologies into investable and licensable business propositions
  4. Connect — Match with US-side partners: investors, corporate development teams, accelerators, and strategic buyers
  5. Execute — Support market entry through US-based operational infrastructure

US Office Network

To maximize geographic coverage and sector alignment, the venture will establish three US offices:

Office Location Primary Focus
West Silicon Valley, CA AI, software, semiconductor, deep tech; VC and startup ecosystem access
Central Texas (Austin or Dallas–Fort Worth area) Manufacturing, energy, advanced materials; corporate partnership development
East East Coast (to be determined) Biotech, pharma, government/defense; institutional and policy access

Each office will serve as a landing pad for Korean technologies entering the US market, providing local market intelligence, partner introductions, and operational support.

Strategic Assets of Each Partner

BSR Korea (백승락 대표이사)

  • 20+ years of institutional relationship-building across Korean TLOs and government bodies
  • Proven track record of winning government-issued projects, including direct appointments by the City of Daejeon
  • Deep access to the Daejeon Daedeok Innopolis ecosystem and national research institutes
  • Established operational infrastructure in Korea for sourcing and due diligence
  • Existing partnerships with Jeonbuk Special Self-Governing Province and other regional governments

Sunghee Yun, Ph.D.

  • Founder & Board Chair, Silicon Valley AI Nexus — a premier Korea–Silicon Valley AI community with institutional partnerships spanning the Korean Consulate General in San Francisco, KOTRA Silicon Valley, KIC Silicon Valley, SNU College of Engineering, K-BioX, and others
  • Co-Founder & CTO, Erudio Bio, Inc. (US) and Co-Founder & CEO, Erudio Bio Korea, Inc. — an AI-powered cancer diagnostics and drug discovery startup that has secured a $1M Gates Foundation Grant, established joint development partnerships with major Korean hospitals (SNUBH, Seoul Asan, Keimyung University Dongsan Hospital), and is actively navigating both US and Korean regulatory pathways (MFDS/IRB). This dual-entity, cross-border biotech venture serves as direct, objective evidence of Sunghee Yun’s ability to build and operate a Korea–US technology commercialization pipeline from inception through regulatory execution — precisely the competency this venture studio requires
  • Extensive network of C-level executives, investors, journalists, legal professionals, and institutional leaders across the US
  • Growing portfolio of MOU partnerships reflecting high perceived value of collaboration with AI Nexus
  • Domain expertise across AI, biotechnology, and semiconductors — directly aligned with Korea’s core R&D strengths
  • Stanford Ph.D. pedigree and 20+ year career spanning Samsung (12 years), Amazon (Senior Applied Scientist, Project creating USD 200M), SK Group spun-off Gauss Labs (Co-Founder & CTO), and biotech entrepreneurship (Erudio Bio & Erudio Bio Korea)

Roles and Responsibilities

Given the breadth of Sunghee Yun’s existing commitments (11 concurrent professional titles across Erudio Bio, Silicon Valley AI Nexus, academic appointments, and advisory roles), the partnership must be structured to maximize strategic leverage while preserving operational bandwidth.

백승락 대표이사 — Operational Lead (Korea Side)

  • Lead technology sourcing and TLO relationship management
  • Manage Korean government relations, grant applications, and institutional partnerships
  • Conduct initial technology screening and due diligence
  • Oversee Korea-side staffing and operations

Sunghee Yun — Strategic Lead (US Side)

  • Serve as the public-facing strategic leader for US operations
  • Leverage AI Nexus network and reputation for deal flow, partnerships, and credibility
  • Provide high-level introductions to investors, corporate partners, and institutional contacts
  • Advise on technology evaluation in AI, biotech, and semiconductor domains
  • Participate in key partner meetings, investor presentations, and marquee events
  • Not responsible for day-to-day US office operations (to be delegated to hired operational leadership)

To Be Hired — US Operations Director(s)

  • Manage daily operations of the three US offices
  • Execute on deal pipeline, partner follow-ups, and administrative functions
  • Report to both partners on progress and pipeline metrics

Governance Structure

  • Joint decision-making on strategic direction, major partnerships, and technology portfolio selection
  • Quarterly strategic reviews between both partners (aligned with 백승락 대표이사’s regular US travel schedule & Sunghee Yun’s regular Korean travel schedule)
  • Independent operational authority for each partner within their respective geographic domains
  • Formal joint venture agreement to define equity split, capital contributions, decision rights, IP ownership, and exit provisions (to be drafted by legal counsel)

Revenue Model

The venture can generate revenue through multiple streams:

Revenue Stream Description
Licensing fees Facilitating technology license agreements between Korean TLOs and US entities
Equity participation Taking equity stakes in spin-off companies formed around commercialized technologies
Consulting / advisory fees Providing market entry advisory services to Korean institutions
Government project fees Executing government-contracted technology transfer and internationalization programs
Event and program fees Hosting technology showcases, investor matchmaking events, and delegation programs

Preliminary Timeline

Phase Timeframe Key Activities
Phase 0 — Agreement Q3 2026 Finalize JV terms, legal structure, equity and governance framework
Phase 1 — Foundation Q4 2026 Establish first US office (Silicon Valley); begin technology pipeline development
Phase 2 — Expansion H1 2027 Launch second US office; execute first 3–5 technology commercialization deals
Phase 3 — Scale H2 2027–2028 Open third US office; build repeatable deal pipeline; pursue government program contracts

Key Success Factors

  1. Clear role boundaries — Operational execution must not depend on Sunghee Yun’s daily involvement; strong US-side operational hires are critical from Phase 1
  2. Hiring the right people in the US — The ideal US-side operators must possess a rare combination of attributes: an extensive professional network with active network-building capability, native-level English fluency, deep understanding of both Korean and American business cultures, and strong communication skills to bridge the two worlds seamlessly. The archetype is someone who was born and raised in Korea yet has lived in the US long enough — ideally since a young age — to operate with English proficiency indistinguishable from a native speaker and an intuitive, lived grasp of cross-cultural dynamics on both sides. In practice, finding such individuals is extraordinarily difficult; if it were easy, this type of Korea–US bridge business would already be commonplace. Recruitment for these roles must therefore be treated as a strategic priority, not an operational afterthought
  3. Quality over volume — Focus on a curated portfolio of high-potential technologies rather than attempting to process everything available
  4. Institutional trust — Leverage both partners’ reputations to build trust on both the Korean and US sides simultaneously
  5. Government alignment — Continue to win government-issued projects (발주) as a revenue and credibility anchor
  6. Network compounding — Each successful deal strengthens the network, making subsequent deals easier; the AI Nexus ecosystem is a force multiplier

Next Steps

  1. Both partners to review and align on this proposal framework
  2. Identify and engage legal counsel to draft the joint venture agreement
  3. Define capital contribution structure and initial operating budget
  4. Begin recruitment planning for US Operations Director (Silicon Valley office)
  5. Develop initial technology pipeline: identify 5–10 candidate technologies from BSR Korea’s existing TLO relationships for preliminary evaluation

This proposal represents a starting framework for discussion. All terms, structures, and timelines are subject to mutual agreement and formal legal documentation.